Valuation Gan & Lee Pharmaceuticals.

Equities

End-of-day quote Shanghai S.E. Other stock markets 17/01/2025			5-day change	1st Jan Change
42.50 ^CNY	+0.69%		+3.68%	-3.63%

01-02	Tranche Update on Gan & Lee Pharmaceuticals.'s Equity Buyback Plan announced on September 6, 2024.	CI
12-16	Gan & Lee Pharmaceuticals.(SHSE:603087) dropped from Shanghai Stock Exchange 180 Value Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	74,247	39,499	18,429	31,066	25,376	25,376	-
Change	-	-46.8%	-53.34%	68.57%	-18.32%	0%	-
Enterprise Value (EV) ¹	74,247	39,499	18,429	28,627	22,842	22,143	21,188
Change	-	-46.8%	-53.34%	55.34%	-20.21%	-3.06%	-4.31%
P/E ratio	57.2x	27.2x	-41.8x	87.8x	37.4x	21.8x	16.7x
PBR	8.31x	3.88x	-	2.91x	2.24x	2.06x	1.87x
PEG	461.43x	2.2x	0x	-0x	0.4x	0.3x	0.5x
Capitalization / Revenue	22.1x	10.9x	-	11.9x	7.45x	5.59x	4.6x
EV / Revenue	22.1x	10.9x	-	11x	6.71x	4.87x	3.84x
EV / EBITDA	-	-	-	53.2x	25.3x	14.5x	11.1x
EV / EBIT	51.1x	23.2x	-	90.8x	29.8x	16.3x	11.9x
EV / FCF	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	0.2	0.16	0.195	0.225
Rate of return	-	-	-	0.38%	0.38%	0.46%	0.53%
EPS ²	2.31	2.59	-0.78	0.6	1.138	1.952	2.548
Distribution rate	-	-	-	33.3%	14.1%	9.99%	8.83%
Net sales ¹	3,362	3,612	-	2,608	3,406	4,542	5,512
EBITDA ¹	-	-	-	537.8	903.7	1,525	1,901
EBIT ¹	1,453	1,699	-	315.3	767	1,362	1,779
Net income ¹	1,231	1,453	-439.5	340.1	680	1,166	1,524
Net Debt ¹	-	-	-	-2,439	-2,534	-3,233	-4,188
Reference price ²	132.22	70.34	32.58	52.65	42.50	42.50	42.50
Nbr of stocks (in thousands)	561,540	561,540	565,653	590,049	597,089	597,089	-
Announcement Date	14/04/21	27/04/22	30/03/23	24/04/24	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield	Capi. ($)
GAN & LEE PHARMACEUTICALS.	37.36x	6.71x	25.28x	+0.38%	3.46B
CSL LIMITED	26.76x	5.84x	17.11x	+1.74%	82.77B
SAMSUNG BIOLOGICS CO.,LTD.	72.63x	15.84x	38.39x	-.--%	49.62B
UCB	64.36x	6.05x	25.4x	+0.77%	35.63B
BIOGEN INC.	11.01x	2.5x	6.97x	-.--%	20.48B
INCYTE CORPORATION	187.12x	2.69x	54.65x	-.--%	13.86B
INTRA-CELLULAR THERAPIES, INC.	-177.6x	18.54x	-115.39x	-.--%	13.41B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	338.96x	-	-	+0.07%	12B
BIOMARIN PHARMACEUTICAL INC.	30.51x	3.91x	19.72x	-.--%	11.73B
ALTEOGEN INC.	706.09x	193.35x	981.26x	-	11.26B
Average	129.72x	28.38x	117.04x	+0.33%	25.42B
Weighted average by Cap.	82.81x	16.79x	61.70x	+0.71%